Combination of Pyrosequencing
Combination of Pyrosequencing
About this item
Full title
Author / Creator
Publisher
Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
sequencing is crucial for therapeutic decisions in treatment regimens of lung cancer patients. Several mutations have been identified in the past, of which some were confirmed as activating or resistance mutations by
phenotyping. In this study, novel mutations of so far unknown relevance were identified by a combination of Sanger and Pyrosequenc...
Alternative Titles
Full title
Combination of Pyrosequencing
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_futurescience_futuremedicine_10_2217_pme_12_122
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_futurescience_futuremedicine_10_2217_pme_12_122
Other Identifiers
ISSN
1741-0541
E-ISSN
1744-828X
DOI
10.2217/pme.12.122